MetLife, Inc.

New York Stock Exchange
Back to all articles
Bullish +75

MetLife stock trades at USD 97.25 as Q3 estimate emerges

Analyst upgrade Earnings report AI-generated analysis

📈 MetLife stock traded at USD 97.25 on September 24, 2026, trading near its 52-week high of USD 100.93 with a market cap of USD 62.57 billion.

💰 The insurer estimated Q3 variable investment income at least USD 600 million pre-tax, contributing to full-year guidance of USD 1.6 billion.

📊 Q2 adjusted EPS rose 20 percent year over year to USD 2.43, with diluted GAAP EPS reaching USD 1.09.

🎯 Adjusted ROE hit 17 percent, achieving the top of the company's annual target range of 15 percent to 17 percent.

🚀 Piper Sandler upgraded MetLife to Overweight with a price target of USD 110.00, indicating analyst confidence in valuation upside.

🏆 Group Benefits adjusted earnings increased 25 percent year over year to USD 503 million in Q2 2026.

✅ The Group Life mortality ratio improved to 79 percent, beating the company's target range of 83 percent to 88 percent.

Bullish Signals
  • MetLife stock is trading near its 52-week high of USD 100.93 at USD 97.25, indicating strong market confidence and momentum.
  • Q2 adjusted earnings per share surged 20 percent year over year to USD 2.43, demonstrating robust profitability growth.
  • The company achieved an adjusted ROE of 17 percent, successfully hitting the top end of its annual target range.
  • Group Benefits adjusted earnings jumped 25 percent year over year to USD 503 million, showing strong segment performance.
  • The Group Life mortality ratio improved to 79 percent, significantly outperforming the company's internal target range.
  • Piper Sandler upgraded MetLife to Overweight with a price target of USD 110.00, suggesting substantial upside potential from current levels.
  • Preliminary Q3 variable investment income is estimated at least USD 600 million pre-tax, supporting strong full-year guidance.
Full Analysis
MetLife Inc. stock traded at USD 97.25 on the NYSE on September 24, 2026, approaching its 52-week high of USD 100.93 with a market capitalization of USD 62.57 billion. The insurer provided preliminary estimates for Q3 variable investment income of at least USD 600 million pre-tax, which serves as an early operating signal ahead of its scheduled results release on November 4, 2026. In the second quarter of 2026, MetLife reported diluted GAAP EPS of USD 1.09 and consolidated net income of USD 779 million. On an adjusted basis, earnings reached USD 2.43 per share, representing a 20 percent year-over-year increase. The company achieved an adjusted Return on Equity (ROE) of 17 percent, hitting the top end of its annual target range between 15 percent and 17 percent. Analyst sentiment remains positive with Piper Sandler upgrading MetLife to Overweight and setting a price target of USD 110.00, which implies significant upside from current levels. Additionally, Group Benefits adjusted earnings surged 25 percent year over year to USD 503 million, driven by a mortality ratio of 79 percent that outperformed the company's internal target range. The article highlights MetLife's strong financial performance across investment income and underwriting metrics, supported by institutional upgrades. While the Q3 estimate is preliminary and unaudited, it suggests robust contribution toward the full-year guidance of USD 1.6 billion in pre-tax variable investment income.